Graham Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-8,417
| Closed | -$344K | – | 1374 |
|
|
2024
Q2 | $344K | Buy |
+8,417
| New | +$344K | 0.01% | 661 |
|
|
2023
Q4 | – | Sell |
-41,850
| Closed | -$914K | – | 1389 |
|
|
2023
Q3 | $914K | Buy |
41,850
+31,506
| +305% | +$688K | 0.02% | 378 |
|
|
2023
Q2 | $329K | Buy |
+10,344
| New | +$329K | 0.01% | 643 |
|